Effectiveness of treatment in Parkinsons disease
Not Applicable
- Conditions
- Health Condition 1: G20- Parkinsons disease
- Registration Number
- CTRI/2019/03/017955
- Lead Sponsor
- Department of Neurology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Parkinsonâ??s disease patients (fulfilling MDS clinical diagnostic criteria for PD) (who are currently taking or had taken trihexyphenidyl in the past)
Exclusion Criteria
1.Patients with cognitive and behavioral disturbances.
2.Patients with history of urinary disturbances and benign hyperplasia of prostate.
3.Patients with angle closure glaucoma.
4.Patients with h/o cardiac illness
5.Patients with h/o postural hypotension.
6.Lack of consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in UPDRS motor scores after the treatmentTimepoint: Baseline, after 1 hour of levodopa tablets, after 48 hours, after 30 minutes, after 60 minutes, after 90 minutes, after 120 minutes
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI